NCT05557604RecruitingPhase 2
Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer
Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer (STUNNIN): A Randomized Phase II Study
Source: ClinicalTrials.gov · Last updated 28 Sept 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a prospective, open, randomized phase II trial.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 146 (estimated)
- First submitted
- 23 Sept 2022
- Start date
- 2 Feb 2021
- Primary completion date
- 2 Feb 2024
- Lead sponsor
- Regina Elena Cancer Institute
- Diseases
- Prostate cancer
- NCT number
- NCT05557604
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 146
- From 2 Feb 2021 to the primary completion date, 2 Feb 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous local treatment of the prostate with surgery (radical prostatectomy or cryotherapy)
- Previous radiotherapy to the pelvis
- Previous chemotherapy for malignancy in past 5 years
- Impossibility to implant fiducials for tracking purposes
Other
- Impossibility to undergo MRI of the prostate
- Contraindication to short term AD
- Prostate volume \>90cc
Who the study is looking for
- Histologically proven prostate adenocarcinoma
- IR or HR in the NCCN definition
- N0M0 at staging with choline or (preferably) PSMA PET-CT;
- ECOG performance status between 0 and 2;
Age in the registry: 18 years to 90 years · Sex: Male · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Regina Elena National Cancer Institute Coordinator of this site? Confirm its status | Rome | Italy | Recruiting |
| Ifo Regina Elena Coordinator of this site? Confirm its status | Rome | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.